Overview of virus and cancer relationships. Position paper.
Journal
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
ISSN: 1988-9518
Titre abrégé: Rev Esp Quimioter
Pays: Spain
ID NLM: 9108821
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
pubmed:
6
8
2021
medline:
27
11
2021
entrez:
5
8
2021
Statut:
ppublish
Résumé
The role of certain viruses in the etiology of some tumors is today indisputable, but there is a lack, however, of annoverview of the relationship between viruses and cancer with amultidisciplinary approach. For this reason, the Health Sciences Foundation has convened a group of professionals from different areas of knowledge to discuss the relationship between viruses and cancer, and the present document is the result of these deliberations. Although viruses cause only 10-15% of cancers, advances in oncology research are largely due to the work done during the last century on tumor viruses. The clearest cancer-inducing viruses are: HPV, HBV, HCV, EBV and, depending on the geographical area, HHV-8, HTLV-1 and HIV. HPVs, for example, are considered to be the causative agents of cervical carcinomas and, more recently, of a proportion of other cancers. Among the Herpes viruses, the association with the development of neoplasms is well established for EBV and HHV-8. Viruses can also be therapeutic agents in certain neoplasms and, thus, some oncolytic viruses with selective tropism for tumor cells have been approved for clinical use in humans. It is estimated that the prophylaxis or treatment of viral infections could prevent at least 1.5 million cancer deaths per year.
Identifiants
pubmed: 34348449
doi: 10.37201/req/058.2021
pmc: PMC8638760
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
525-555Informations de copyright
©The Author 2021. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
Références
N Engl J Med. 1998 Apr 2;338(14):948-54
pubmed: 9521982
Eur J Cancer. 2011 Mar;47(5):742-7
pubmed: 21194924
Gastroenterology. 2019 Jul;157(1):54-64
pubmed: 30986389
Eur J Epidemiol. 2018 Mar;33(3):263-274
pubmed: 29214413
Adv Virus Res. 2006;66:125-59
pubmed: 16877060
Virol J. 2013 Jun 06;10:182
pubmed: 23741982
BMJ. 2019 Apr 3;365:l1161
pubmed: 30944092
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Oct;37(8):502-508
pubmed: 30679001
CA Cancer J Clin. 1977 May-Jun;27(3):174-81
pubmed: 406018
Acta Pharmacol Sin. 2017 Aug;38(8):1093-1103
pubmed: 28392570
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
Gene Ther. 2003 Feb;10(4):292-303
pubmed: 12595888
N Engl J Med. 2015 Nov 5;373(19):1845-52
pubmed: 26535513
Nature. 1982 Apr 1;296(5856):404-9
pubmed: 7063039
Chin Clin Oncol. 2016 Apr;5(2):23
pubmed: 27121883
Health Aff (Millwood). 2018 May;37(5):817-820
pubmed: 29733715
Lancet Glob Health. 2017 Feb;5(2):e139
pubmed: 28104177
Mol Ther. 2012 Apr;20(4):749-58
pubmed: 22186794
J Virol. 2005 Jun;79(12):7641-7
pubmed: 15919916
N Engl J Med. 2018 Feb 8;378(6):549-562
pubmed: 29414277
HIV Med. 2019 Oct;20(9):628-633
pubmed: 31274241
Cancer Lett. 2014 Apr 10;345(2):174-81
pubmed: 23941825
JNCI Cancer Spectr. 2019 Jan 07;2(4):pky045
pubmed: 31360870
Pathogens. 2020 Apr 20;9(4):
pubmed: 32325943
Am Soc Clin Oncol Educ Book. 2019 Jan;39:185-195
pubmed: 31099635
Infect Disord Drug Targets. 2016;16(1):4-21
pubmed: 27052336
J Virol. 1974 Oct;14(4):895-903
pubmed: 4138674
Curr Cancer Drug Targets. 2017;17(6):534-554
pubmed: 27677953
Lancet Oncol. 2012 Jun;13(6):564-5
pubmed: 22575586
Jpn J Clin Oncol. 1983;13 Suppl 2:165-87
pubmed: 6603526
AIDS. 2006 Aug 1;20(12):1645-54
pubmed: 16868446
Lancet. 1991 Feb 9;337(8737):320-2
pubmed: 1671232
Dtsch Med J. 1964 Mar 20;15:200-7
pubmed: 14187129
J Clin Oncol. 1998 Jan;16(1):70-7
pubmed: 9440725
N Engl J Med. 2005 Mar 31;352(13):1317-23
pubmed: 15800227
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Nat Clin Pract Oncol. 2007 Feb;4(2):101-17
pubmed: 17259931
Vaccine. 2019 Jun 27;37(29):3918-3924
pubmed: 31160099
Enferm Infecc Microbiol Clin. 2016 Apr;34(4):222-7
pubmed: 26093959
Trends Parasitol. 2012 Oct;28(10):395-407
pubmed: 22947297
J Natl Cancer Inst. 2002 Nov 6;94(21):1604-13
pubmed: 12419786
Mol Immunol. 1997 Nov-Dec;34(16-17):1167-76
pubmed: 9566764
Curr HIV/AIDS Rep. 2015 Dec;12(4):388-96
pubmed: 26475669
J Natl Cancer Inst. 2004 Feb 18;96(4):256-7
pubmed: 14970271
Cancer. 2007 Feb 25;111(1):34-40
pubmed: 17262799
Chin Clin Oncol. 2018 Apr;7(2):16
pubmed: 29764161
Cancer J. 2011 Sep-Oct;17(5):359-71
pubmed: 21952287
Liver Int. 2017 Jan;37 Suppl 1:136-139
pubmed: 28052619
JAMA Dermatol. 2020 Aug 1;156(8):844-853
pubmed: 32459291
HIV Med. 2016 Sep;17(8):590-600
pubmed: 26890156
J Virol. 2008 Feb;82(3):1448-57
pubmed: 18032491
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4524-8
pubmed: 3012571
Hum Vaccin Immunother. 2015;11(1):53-7
pubmed: 25483515
CA Cancer J Clin. 1970 Jul-Aug;20(4):242-7
pubmed: 4316985
Curr Hematol Malig Rep. 2018 Aug;13(4):300-307
pubmed: 30047026
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
J Korean Assoc Oral Maxillofac Surg. 2016 Dec;42(6):327-336
pubmed: 28053902
AIDS. 2015 Oct 23;29(16):2173-81
pubmed: 26182198
Clin Infect Dis. 2017 Aug 15;65(4):636-643
pubmed: 29017269
Chin J Cancer. 2014 Dec;33(12):581-90
pubmed: 25418193
Curr Opin Virol. 2019 Dec;39:49-59
pubmed: 31525538
Dis Mon. 2019 Jun;65(6):155-163
pubmed: 30502099
Aust N Z J Public Health. 2015 Oct;39(5):446-51
pubmed: 26437730
Viruses. 2018 Oct 02;10(10):
pubmed: 30279347
Immunotargets Ther. 2014 Dec 04;3:151-65
pubmed: 27471706
Viruses. 2016 Jul 20;8(7):
pubmed: 27447661
Oncolytic Virother. 2013 Sep 23;2:31-46
pubmed: 27512656
Oncotarget. 2017 Apr 20;8(42):71489-71499
pubmed: 29069721
Am J Prev Med. 2017 Nov;53(5):705-709
pubmed: 28751055
Cancer Gene Ther. 2008 Dec;15(12):795-807
pubmed: 18535620
Curr Opin Mol Ther. 2008 Aug;10(4):380-6
pubmed: 18683103
Stud Hist Philos Biol Biomed Sci. 2014 Dec;48 Pt B:185-8
pubmed: 25448539
Asian J Androl. 2012 Jul;14(4):520-1
pubmed: 22580638
J Exp Med. 1959 Oct 1;110:543-6
pubmed: 13834926
J Natl Cancer Inst. 2010 Jun 2;102(11):784-92
pubmed: 20442214
BMB Rep. 2016 Nov;49(11):590-597
pubmed: 27418285
J Immunother Cancer. 2018 Dec 4;6(1):140
pubmed: 30514385
Oncotarget. 2017 Mar 21;8(12):19255-19273
pubmed: 27926486
Ann Transl Med. 2020 May;8(10):650
pubmed: 32566587
Proc Natl Acad Sci U S A. 1982 May;79(9):2845-9
pubmed: 6953433
Crit Rev Oncog. 2018;23(3-4):219-234
pubmed: 30311576
Ann Oncol. 2012 Apr;23(4):997-1005
pubmed: 21821548
PLoS One. 2014 Apr 23;9(4):e94768
pubmed: 24760049
Proteomics. 2012 Jul;12(13):2127-38
pubmed: 22623378
Onco Targets Ther. 2019 Dec 31;12:11793-11804
pubmed: 32099385
Cancer Res. 2002 Dec 1;62(23):6952-8
pubmed: 12460912
Curr Opin Virol. 2018 Oct;32:60-70
pubmed: 30268927
Infect Agent Cancer. 2017 Apr 11;12:19
pubmed: 28400857
Front Med (Lausanne). 2019 Mar 22;6:55
pubmed: 30968025
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
Nat Rev Cancer. 2018 Sep;18(9):586-595
pubmed: 29899559
Annu Rev Immunol. 2015;33:787-821
pubmed: 25706097
Cancer Sci. 2019 Apr;110(4):1132-1139
pubmed: 30697862
Am J Epidemiol. 2014 Sep 15;180(6):599-607
pubmed: 25139208
Oncogene. 2008 Dec;27 Suppl 2:S31-42
pubmed: 19956178
Transplantation. 2009 Oct 27;88(8):1025-9
pubmed: 19855249
J Transl Med. 2015 Feb 06;13:50
pubmed: 25885535
Trop Geogr Med. 1981 Mar;33(1):1-7
pubmed: 7018036
Medicine (Baltimore). 2002 Jul;81(4):293-304
pubmed: 12169884
Br J Cancer. 2011 Dec 6;105 Suppl 2:S49-56
pubmed: 22158321
J Infect Dev Ctries. 2010 Jun 03;4(5):267-81
pubmed: 20539059
Nat Rev Cancer. 2010 Dec;10(12):878-89
pubmed: 21102637
Fed Proc. 1958 Dec;17(4):994-1003
pubmed: 13619763
N Engl J Med. 2004 Mar 25;350(13):1328-37
pubmed: 15044644
Cancer Res. 2013 Feb 15;73(4):1265-75
pubmed: 23393196
Cell. 1982 May;29(1):161-9
pubmed: 6286138
Cancer Res. 2013 Mar 15;73(6):1676-88
pubmed: 23348421
Clin Transl Immunology. 2015 Jan 23;4(1):e32
pubmed: 25671130
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15036-41
pubmed: 12409611
J Immunol Res. 2018 Mar 26;2018:8740976
pubmed: 29785403
Int J Mol Sci. 2019 Mar 18;20(6):
pubmed: 30889843
Virology. 1959 Jan;7(1):75-91
pubmed: 13636057
Cancer Res. 2012 May 15;72(10):2609-21
pubmed: 22461509
J Infect Dis. 2009 Apr 1;199(7):926-35
pubmed: 19236279
Surgery. 1964 May;55:654-64
pubmed: 14146525
Front Oncol. 2019 Feb 25;9:104
pubmed: 30859093
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5188-93
pubmed: 10220441
Int J Cancer. 2020 Apr 15;146(8):2089-2103
pubmed: 31254479
Int J Cancer. 1979 Jun 15;23(6):762-7
pubmed: 223991
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):332-339
pubmed: 27331659
Arch Dermatol. 2001 Jun;137(6):730-4
pubmed: 11405761
Int J Cancer. 2011 Sep 15;129(6):1289-99
pubmed: 21445966
Cell. 2015 Aug 27;162(5):1090-100
pubmed: 26279189
Lancet. 2016 Mar 5;387(10022):1012-1024
pubmed: 26321262
Cancer. 2017 Jul 1;123(13):2404-2412
pubmed: 28464289
Clin Cancer Res. 2014 Oct 1;20(19):5009-22
pubmed: 25124688
Enferm Infecc Microbiol Clin (Engl Ed). 2019 May;37(5):314-318
pubmed: 31036251
Proc Natl Acad Sci U S A. 1974 Oct;71(10):3874-8
pubmed: 4372595
J Virol. 2011 Dec;85(24):13105-13
pubmed: 21994444
Lancet Glob Health. 2017 Feb;5(2):e140
pubmed: 28104178
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301
J Hepatol. 2016 Oct;65(4):719-726
pubmed: 27084592
Curr Drug Metab. 2018;19(9):798-805
pubmed: 29512446
Am J Prev Med. 2018 Aug;55(2):197-204
pubmed: 29859731
Int J Cancer. 2000 Dec 15;88(6):949-55
pubmed: 11093820
Int J Cancer. 2018 May 15;142(10):2186-2187
pubmed: 29280138
Proc Soc Exp Biol Med. 1959 Jul;101(3):575-8
pubmed: 13675323
Cancer Treat Res. 2019;177:63-80
pubmed: 30523621
J Hepatol. 2016 Oct;65(4):864-865
pubmed: 27255581
Semin Liver Dis. 2017 May;37(2):109-118
pubmed: 28388736
Front Biosci. 2008 May 01;13:5916-27
pubmed: 18508632
Am J Clin Dermatol. 2017 Feb;18(1):1-15
pubmed: 27988837
Infect Agent Cancer. 2018 May 2;13:15
pubmed: 29743937
J Clin Virol. 2005 Mar;32 Suppl 1:S59-66
pubmed: 15753013
Cancer. 1974 Oct;34(4 Suppl):suppl:1421-6
pubmed: 4371153
Lancet Oncol. 2014 Nov;15(12):1319-31
pubmed: 25439690